A roundup of all the latest news on www.globaluniversityventuring.com for our subscribers.

Big deal: Nightstar shines bright in $800m acquisition Nightstar Therapeutics, based on Oxford research, stands to receive $800m from Biogen in an acquisition deal that comes a year and a half after completing a $75m IPO. Imperial internalises tech transfer ICL will restore internal tech transfer activities from its Imperial White City Incubator, in the process ending its arrangement with commercialisation firm IP Group. Larter lands at Calgary Stephen Larter has become Calgary’s associate vice-president for research and innovation, adding to his duties as chief scientist of the university’s CDL-Rockies accelerator for energy startups. Sarepta rakes in Myonexus for $165m Sarepta Therapeutics exercised its option to acquire Nationwide Children’s gene therapy spinout Myonexus Therapeutics after paying at least $60m for the right in May 2018. New Orleans institutions prepare life sciences accelerator Tulane University and LSU Health Sciences Center have selected New Orleans BioInnovation Center to administer life sciences accelerator services. Arizona releases Fibronox Fibronox spun out from University of Arizona’s College of Medicine – Tucson in 2017 to deliver Nox4-inhibiting drugs for fibrotic disorders including lung fibrosis. Pozyx places $1.5m Ghent-founded indoor position technology business Pozyx has amassed more than $1.5m having recently completed the launch of its initial product range. Utah enters Recursion for incubator University of Utah’s TVC commercialisation office is to open a new incubator with Recursion, itself a Utah spinout, to provide facilities including wet lab and co-working space. WZL processes Iconpro Process management technology developer Iconpro was founded out of RWTH Aachen last year and is targeting its services at the manufacturing sector. Precision Bio pinpoints $100m IPO target Genomic medicine developer Precision Biosciences plans to raise up to $100m in an upcoming IPO that could hand exits to Duke University and corporates Amgen, EMS and Baxter. Gintel Technology to purify $30m round Kao Yuan University’s Gintel has created water quality monitoring systems that can provide information on 50 parameters of toxicity and recommend remedies. NovaGo collects $10m Zurich brain injury antibody spinout NovaGo has extended its strategic partnership with immunotherapy company Neurimmune by securing its support in a series A round. Vilmorin & Cie joins PSL Innovation Fund Vilmorin & Cie has joined fellow corporates including BNP Paribas, Naval Group and MGEN as an investor in the targeted $87.5m PSL Innovation Fund. Refeyn rates $3.4m Oxford-founded biopharmaceutical development instrument manufacturer Refeyn has secured funding from the university and OSI to help scale manufacturing and distribution. Utec and Blume illuminate Budha accelerator University of…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?